Bioabsorbable Stents Market Size, Share Global Analysis Report, 2020–2026

Industry Insights

[178+ Pages Report] According to the report published by Facts Factors, the bioabsorbable stents market size was worth around USD 186.5 Million in 2019 and is predicted to grow to around USD 361.87 Million by 2026  with a compound annual growth rate (CAGR) of roughly 10.0% between 2020  and 2026. The report analyzes the global bioabsorbable stents market drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the bioabsorbable stents market.

This specialized and expertise-oriented industry research report scrutinizes the technical and commercial business outlook of the bioabsorbable stents industry. The report analyzes and declares the historical and current trends analysis of the bioabsorbable stents industry and subsequently recommends the projected trends anticipated to be observed in the bioabsorbable stents market during the upcoming years.

Key Insights from Primary Research

• According to the primary CXOs of the global bioabsorbable stents market, the market is estimated to witness a substantial growth of nearly 10.0% over the forecast period.
• The market was valued at USD 170 million, in 2019 and is expected to be valued at over USD 350 million.
• On the basis of the type segment, coronary artery diseases dominated the global bioabsorbable stents market in 2019. In terms of revenue, it accounted for a significant share of the total market in 2019.
• Asia Pacific market is expected to be the fastest goring region for bioabsorbable stents over the forecast period owing to growing investments for R&D and pharmaceutical companies in the region.
• By geography, the North American region headed the market with the highest share in 2019.

Key Recommendations from Analysts

• The strategic developments such as regional expansion, product innovations, and ongoing research and developments by the major companies such as Abbott Laboratories, STENTYS SA, Biotronik SE & Co. KG, and Microport Scientific Corporation are likely to boom the market’s growth over the upcoming years.
• Our analysts recommend that the Asia Pacific region is predicted to witness significant growth. 
• Strengthening the distribution channel may also help the major player to cater the lucrative growth of the market over the years to come.

Market Share Analysis by Application

The quantitative data is further underlined and reinforced by comprehensive qualitative data which comprises various across-the-board market dynamics. The rationales which directly or indirectly impact the bioabsorbable stents industry are exemplified through parameters such as growth drivers, restraints, challenges, and opportunities among other impacting factors.

Throughout our research report, we have encompassed all the proven models and tools of industry analysis and extensively illustrated all the key business strategies and business models adopted in the bioabsorbable stents industry. The report provides an all-inclusive and detailed competitive landscape prevalent in the bioabsorbable stents market.

The report utilizes established industry analysis tools and models such as Porter’s Five Forces framework to analyze and recognize critical business strategies adopted by various stakeholders involved in the entire value chain of the bioabsorbable stents industry. The bioabsorbable stents market report additionally employs SWOT analysis and PESTLE analysis models for further in-depth analysis.

The report study further includes an in-depth analysis of industry players' market shares and provides an overview of leading players' market position in the bioabsorbable stents sector. Key strategic developments in the bioabsorbable stents market competitive landscape such as acquisitions & mergers, inaugurations of different products and services, partnerships & joint ventures, MoU agreements, VC & funding activities, R&D activities, and geographic expansion among other noteworthy activities by key players of the bioabsorbable stents market are appropriately highlighted in the report.

The bioabsorbable stents market research report delivers an acute valuation and taxonomy of the bioabsorbable stents industry by practically splitting the market on the basis of different types, category, and regions. Through the analysis of the historical and projected trends, all the segments and sub-segments were evaluated through the bottom-up approach, and different market sizes have been projected for FY 2020 to FY 2026. The regional segmentation of the bioabsorbable stents industry includes the complete classification of all the major continents including North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Further, country-wise data for the bioabsorbable stents industry is provided for the leading economies of the world.

Geriatric population base which is more vulnerable to stroke needs stent implants for treatment, growing acceptance rates of these devices, advances in technology, and risk of restenosis in patients suffering from angioplasty are some of the factors that fuel demand growth for bioabsorbable stent.

The global bioabsorbable stents market has been segmented on the basis of material, absorption rate, application as well as end user. On the basis of material segment the target market is segmented into polymer based stents and metallic stents. On the basis of en user segment the global market can be segmented as hospitals, cardiac centers, and others.

Report Scope

Some of the essential players operating in the bioabsorbable stents market are as follows:

•  Abbott Laboratories
•  STENTYS SA
•  Biotronik SE & Co. KG
•  Microport Scientific Corporation
•  B. Braun Melsungen AG
•  Boston Scientific Corporation
•  Terumo Corporation
•  Medtronic Plc
•  Elixir Medical Corporation
•  C.R.Bard Inc.

The taxonomy of the bioabsorbable stents industry by its scope and segmentation is as follows:

Material Segment Analysis

• Polymer Based Stents
• Metallic Stents

Absorption Rate Segment Analysis

• Slow- Absorption Stents
• Fast- Absorption Stents

Application Segment Analysis

• Coronary Artery Diseases
• Peripheral Artery Diseases

End User Segment Analysis

• Hospitals
• Cardiac Centers
• Others

Regional Segmentation Analysis

• North America
  • The U.S.
  • Canada
• Europe
  • Germany
  • The UK
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa